Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.046 | 0.8 |
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |